PedAM
Pediatric Disease Annotations & Medicines
| Disease | arthritis |
| Phenotype | C0004153|atherosclerosis |
| Sentences | 33 |
| PubMedID- 21420089 | Objective: to assess the influence of the tnfa rs1800629 (g > a) polymorphism in the risk of cardiovascular (cv) disease and subclinical atherosclerosis in patients with rheumatoid arthritis (ra). |
| PubMedID- 20213808 | Objective: the prevalence of subclinical coronary atherosclerosis is increased in patients with rheumatoid arthritis (ra), and the increased risk is associated with insulin resistance. |
| PubMedID- 22899879 | To determine whether treatment with the anti-tnf-alpha blocker adalimumab yields persistent improvement of endothelial function and prevents from morphological progression of subclinical atherosclerosis in patients with rheumatoid arthritis (ra) refractory to conventional therapy, a series of 34 consecutive ra patients, attending hospital outpatient clinics and who were switched from disease modifying antirheumatic drug therapy to anti-tnf-alpha-adalimumab treatment because of severe disease, were assessed by ultrasonography techniques before the onset of adalimumab therapy (at day 0) and then at day 14 and at month 12. |
| PubMedID- 22645614 | The eular recommendations recognize the association between inflammation and atherosclerosis in patients with inflammatory arthritis and recommend that aggressive suppression of disease activity or inflammation is necessary to lower the cardiovascular risk. |
| PubMedID- 21632673 | Objective: to identify the presence of subclinical atherosclerosis in patients with psoriatic arthritis (psa) and healthy controls using intima-media thickness (imt), coronary flow reserve (cfr), and the plasma concentration of asymmetric dimethylarginine (adma), to evaluate the correlations among adma, imt, and cfr. |
| PubMedID- 22000818 | Objectives: rheumatoid arthritis (ra) is associated with premature atherosclerosis and increased prevalence of cardiovascular disease. |
| PubMedID- 20346241 | Objectives: to assess whether the polymorphism of the macrophage migration inhibitory factor (mif) gene at the position -173 is implicated in the disease susceptibility, risk of cardiovascular (cv) events and presence of subclinical atherosclerosis in patients with rheumatoid arthritis (ra). |
| PubMedID- 25956924 | We hypothesized that glyca is a biomarker of disease activity and is associated with coronary artery atherosclerosis in patients with rheumatoid arthritis (ra). |
| PubMedID- 24693449 | This was seen in a population of psoriatic arthritis patients with subclinical atherosclerosis [52]. |
| PubMedID- 25772817 | Vascular abnormalities predisposing to atherosclerosis are present in patients with rheumatoid arthritis (ra) and associate with excess cardiovascular risk. |
| PubMedID- 23295110 | Objectives: rheumatoid arthritis (ra) is associated with accelerated atherosclerosis and premature cardiovascular death. |
| PubMedID- 22340996 | Objective: despite the recognized risk of accelerated atherosclerosis in patients with rheumatoid arthritis (ra), little is known about cardiovascular risk management in contemporary cohorts of these patients. |
| PubMedID- 26571131 | Objectives: to determine whether the interleukin-33 (il-33)-interleukin-1 receptor like 1 (il-1rl1) signaling pathway is implicated in the risk of subclinical atherosclerosis in patients with rheumatoid arthritis (ra). |
| PubMedID- 26504820 | This prospective study of an inception cohort aimed to investigate whether the level of lp-pla2 is associated with subclinical atherosclerosis in patients with rheumatoid arthritis (ra). |
| PubMedID- 23273674 | Carotid atherosclerosis in patients with rheumatoid arthritis and rheumatoid nodules. |
| PubMedID- 22736087 | Aim: to compare the extent of atherosclerosis in patients with psoriatic arthritis (psa) and patients with cutaneous psoriasis without arthritis (psc). |
| PubMedID- 24713330 | It is the case of angiopietin-2 or osteoprotegerin that have been found to be good predictors of cardiovascular disease and subclinical atherosclerosis in patients with rheumatoid arthritis [25,26]. |
| PubMedID- 26247590 | Background: to evaluate association between von willebrand factor (vwf) activity, inflammation markers, disease activity, and subclinical atherosclerosis in patients with rheumatoid arthritis (ra) and low cardiovascular risk. |
| PubMedID- 21239756 | Objective: studies indicate that ankylosing spondylitis (as), as well as rheumatoid arthritis, may be associated with accelerated atherosclerosis and vascular disease. |
| PubMedID- 26074962 | In addition, a cause and effect relationship between corticosteroid treatment and premature atherosclerosis was hypothesized in patients with rheumatoid arthritis or systemic lupus erythematosus chronically treated with glucocorticoids [26, 27]. |
| PubMedID- 23941259 | Severe hypercholesterolemia aggravated atherosclerotic plaques instability and aortic lesions mainly due to massive mφ infiltration in our animal rabbit model of atherosclerosis associated with chronic arthritis [16]. |
| PubMedID- 21490773 | Inflammatory processes in rheumatoid arthritis lead to accelerated atherosclerosis and afflicted patients have an elevated risk for cardiovascular events leading to a higher mortality [1]. |
| PubMedID- 25381982 | Chronic inflammatory diseases such as rheumatoid arthritis (ra) are associated with accelerated atherosclerosis and increased morbidity and mortality for cardiovascular events. |
| PubMedID- 20553683 | Objective: rheumatoid arthritis (ra) is associated with accelerated atherosclerosis in the carotid arteries, but little is known about the magnitude of this process in peripheral arteries. |
| PubMedID- 21780652 | Aim: to study the role of conventional and new factors of cardiovascular risk in development of atherosclerosis in patients with rheumatoid arthritis (ra) and psoriatic arthritis (pa). |
| PubMedID- 21345288 | Objectives: to assess the influence of the retn rs1862513 polymorphism in the risk of cardiovascular (cv) disease and subclinical atherosclerosis in patients with rheumatoid arthritis (ra). |
| PubMedID- 24827532 | Aim: to investigate whether a higher burden of inflammation is associated with more severe atherosclerosis in patients with psoriatic arthritis (psa). |
| PubMedID- 21281743 | While classical accelerated atherosclerosis has been associated with rheumatoid arthritis (ra), systemic lupus erythematosus (sle) or spondyloarthropathies (spa), obliterative vasculopathy may rather be characteristic for systemic sclerosis (ssc) or mixed connective tissue disease (mctd). |
| PubMedID- 25366205 | Subclinical atherosclerosis in patients with rheumatoid arthritis by utilizing carotid intima-media thickness as a surrogate marker. |
| PubMedID- 22053612 | Subclinical atherosclerosis is increased in patients with rheumatoid arthritis (ra), as chronic systemic inflammation leads to accelerate atherosclerosis and increase arterial stiffness in theses patients. |
| PubMedID- 20337633 | Rheumatoid arthritis (ra) is associated with enhanced atherosclerosis and impaired endothelial function early after the onset of the disease and cardiovascular (cv) disease represents one of the leading causes of morbidity and mortality. |
| PubMedID- 21846359 | Introduction: the aim of our study was to analyze the influence of the ccr5delta32 polymorphism in the risk of cardiovascular (cv) events and subclinical atherosclerosis among patients with rheumatoid arthritis (ra). |
| PubMedID- 21165753 | Therefore, the aim of the study was to determine serum visfatin level and its association with common carotid intima-media thickness (imt), which is a predictor of atherosclerosis, in patients with rheumatoid arthritis (ra), systemic lupus erythematosus (sle), systemic sclerosis (ssc), and behcet's disease (bd). |
Page: 1